Nanalysis Scientific Corp. (NSCIF)

Market Cap	15.79M -35.4%
Revenue (ttm)	29.97M -2.9%
Net Income	-8.89M
EPS	-0.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	16,792
Open	0.1185
Previous Close	0.1194
Day's Range	0.1185 - 0.1185
52-Week Range	0.1020 - 0.2430
Beta	0.09
RSI	48.73
Earnings Date	Apr 24, 2026

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: OTCMKTS
• Ticker Symbol: NSCIF

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.

Financial numbers in CAD